Skip to main content

Table 8 Cardiac findings focusing on functional CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

 

MD

Normal LV and RV function

Impaired LV and/or RV function

p value

N = 63

N = 31

N = 32

LV-EDVi, ml/m2

85 ± 30

73 ± 18

96 ± 35

0.003

LV-ESVi, ml/m2

41 ± 21

27 ± 9

54 ± 21

<0.0001

LV-mass, g/m2

60 ± 16

53 ± 11

66 ± 18

0.001

LV-EF, %

53 ± 12

63 ± 6

44 ± 9

NA

RV-EF, %

53 ± 9

58 ± 7

49 ± 9

NA

LV-EF <55 %, n (%)

29 (46)

0 (0)

29 (91)

NA

RV-EF <45 %, n (%)

10 (16)

0 (0)

10 (31)

NA

LGE presence, n (%)

48 (76)

17 (55)

31 (97)

<0.0001

LGE extent, %

7 (1–17)

1 (0–6)

16 (8–32)

<0.0001

Abnormal CMR, n (%)

49 (78)

17 (55)

32 (100)

NA

  1. Bold text indicates a significant p-value of <0.05